SCHEMBL24176352

SCHEMBL24176352

CCO[Si](CCCN(CCC[Si](OCC)(OCC)OCC)CCC[Si](OCC)(OCC)OCC)(OC)OCC

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30359568 0.96 LMNA (0.36) LMNA
SCHEMBL5170837 0.94 LMNA (0.33) LMNA
SCHEMBL555040 0.91
SCHEMBL23424791 0.91 LCK (0.32)
SCHEMBL24178733 0.91
SCHEMBL22289262 0.89
SCHEMBL30952078 0.89
SCHEMBL26922105 0.87 LMNA (0.32) LMNA
SCHEMBL5960594 0.87 LMNA (0.32) LMNA
SCHEMBL24178903 0.86 LMNA (0.32) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230046963-A1 METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, A DYEING COMPOUND AND A PRE-TREATMENT AGENT HENKEL AG & CO. KGAA (DE) 2023-02-16 US disclosed
US-20220016011-A1 COMPOSITION OF ACTIVE INGREDIENTS, FOR IMPROVING DEPOSITION OF ANTIOXIDANTS HENKEL AG & CO. KGAA (DE) 2022-01-20 US disclosed
US-20220008309-A1 COSMETIC PRODUCT FOR TREATING A KERATIN MATERIAL, COMPRISING A FILM-FORMING AND/OR SETTING CONSTITUENT HENKEL AG & CO. KGAA (DE) 2022-01-13 US disclosed
US-20220000750-A1 THE PROCESS FOR THE PREPARATION AND USE OF HAIR TREATMENT COMPOSITIONS CONTAINING ORGANIC C1-C6 ALKOXY SILANES HENKEL AG & CO. KGAA (DE) 2022-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230046963-A1 METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, A DYEING COMPOUND AND A PRE-TREATMENT AGENT KRT18, DSG1, DSC1 LMNA 32/4885
US-20220000750-A1 THE PROCESS FOR THE PREPARATION AND USE OF HAIR TREATMENT COMPOSITIONS CONTAINING ORGANIC C1-C6 ALKOXY SILANES KRT18, AKR1C3, C9 LMNA 130/4885
US-20220016011-A1 COMPOSITION OF ACTIVE INGREDIENTS, FOR IMPROVING DEPOSITION OF ANTIOXIDANTS KRT18, CAT, POLR1C LMNA 1274/4885
US-20220008309-A1 COSMETIC PRODUCT FOR TREATING A KERATIN MATERIAL, COMPRISING A FILM-FORMING AND/OR SETTING CONSTITUENT KRT18, CUTA, DSG1 LMNA 935/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.